Tetraphase 2012-04 Efficacy of TP-271 in the Mouse Lung Infection Model with Acinetobacter Baumanii

Project Details

StatusFinished
Effective start/end date18/10/12 → 17/10/13

Funding

  • Tetraphase Pharmaceuticals Inc.: $24,050.00

Keywords

  • Infectious Diseases